Contact us

Be prepared for influenza outbreaks with OnSite® 

Each year, influenza outbreaks are responsible for 1 billion estimated infections, 3-5 million cases of severe illness, and up to 650,000 deaths1. Symptoms alone cannot reliably distinguish influenza from other acute febrile infections, and without accurate diagnostic testing, clinicians risk missing the opportunity to intervene before disease severity progresses.  

With OnSite® Influenza Rapid Tests, clinicians and global health systems can stay prepared for influenza outbreaks and guide actionable patient care decisions in 15 minutes or less. 

Why OnSite®? 

Validated performance 

  • Validated against CDC’s recommended strains from 2019-2022, including H1N1, H3N2, H5N1, and Victoria and Yamagata lineages 
  • In-house production of antigens and antibodies ensures rigorous quality standards and consistent performance 
  • No cross-reactivity with other respiratory viruses 

Convenient procedures

  • External controls facilitate internal laboratory quality control 
  • Pre-filled extraction tubes simplify test procedure 
  • Easy sample collection with multiple validated specimen types 

If you have any questions, comments, or collaboration inquiries, you are very welcome to reach out.

Please fill in the form and we will get back to you as soon as possible.




    1. World Health Organization. 2025. “Influenza (Seasonal).” WHO Newsroom Fact Sheets. February 28, 2025. Accessed ↩︎